Bing

WASHINGTON (AP) _ Vanda Pharmaceuticals Inc. (VNDA) on Wednesday reported a loss of $5.4 million in its second quarter. The Washington-based company said it had a loss of 13 cents per share. Losses, adjusted for amortization costs and stock
Yahoo! · 7/29/2015
Your own personalized stock watchlist! It's a 100% FREE Motley Fool service... Click Here Now It's easy to see how Vanda Pharmaceuticals (NASDAQ: VNDA ) can gain Food and Drug Administration approval for its sleep aid Hetlioz by the end of the week.
The Motley Fool · ByBrian Orelli · 1/28/2014
However, the stock has turned around from its $8.00 low and currently trades near $13.00 a share. Number two is Vanda Pharmaceuticals (NASDAQ: VNDA). Institutions currently have 92 percent of the company’s outstanding shares. Vanda’s stock has …
Benzinga · 7/7/2014
The FDA had said VNDA's main developmental drug, Fanapt for schizophrenia, wasn't approvable. End of story. Then, out of nowhere, the FDA shockingly approved it. The stock surged back to life and Vanda once again became a player. But the drug's …
CNBC · 10/13/2009
The stock market registered its second consecutive advance on Wednesday ... EHTH +9.5%, FORM +9.4%, HOLX +9.1%, VNDA +8.6%, PEGA +7.3%, NTRI +7.2%, ANIK +6.7%, TER +6.7%, RKUS +6.6%, EROC +6.3%, EPE +5.6%, HDSN +5.5%, WDC …
Briefing Live Market Analysis · 7/29/2015
Since the stock market bottomed in March, one of the fastest-climbing sectors has been the pharmaceuticals. These issues can be explosive. Pending approval from the necessary regulatory bodies, pharmaceutical developers can see their shares double or ...
Investopedia · 10/24/2009
The article is called Market News: Chesapeake Energy, Gilead Sciences, Vanda Pharmaceuticals and is located at http://www.valuewalk.com/2014/12/market-news-chk-gild-vnda/. You are not ... I better get involved in the stock market.” Gilead Sciences ...
Value Walk · ByMarie Cabural · 12/23/2014
Mr. Milano currently serves on the Boards of Directors of Spark Therapeutics, Vanda Pharmaceuticals (Nasdaq:VNDA) and VenatoRx. He received his Bachelor of Science degree in accounting from Rider College. Idera Pharmaceuticals ... of a stock option …
GlobeNewswire · 12/1/2014
Shares of Vanda Pharmaceuticals (Nasdaq: VNDA) rocketed up by 625% on news that the company's schizophrenia drug, Fanapt, was FDA-approved. Earlier, the stock had opened at $9.99, having closed at $1.08 per share on Wednesday night - that's a …
Investment U · 8/7/2009
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) gained more than 8 percent in after-hours trading ... gained 2.7 percent to $699.77 in post-market trading after the company announced a 7-for-1 stock split. FibroGen Inc (NASDAQ: FGEN) rose 2 percent in …
Morning Star · 6/23/2015